- Home Page /
- Books /
- Science & Math /
- Evolution /
- Genetics /
- JAK2-V617F Mutation In Polycythemia Vera Of I...
JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in
€ 105
Price Details
Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )
*All items will import from US
QTY:
Ubuy works hard to protect your security and privacy. Our advanced payment security system ensures confidentiality by encrypting your information during transmission using AES (Advanced Encryption Standards) and SSL (Secure Socket Layer) protocols. Your payment details are 100% secure as we do not share your payment details with third party sellers.
Genetic studies in the future we hope to be able to cure this disease is very dangerous.
Fast
Shipping
Free
Return*
Secure Packaging
100% Original Products
PCI DSS Compliance
ISO 27001 Certified
What Stands Out
Product Details
| Item Weight | 1 lbs (450 grams) |
Who Should Buy?
-
Healthcare Professionals
Doctors and researchers studying myeloproliferative disorders can gain valuable insights from this comprehensive evaluation.
-
Genetics Students
Students specializing in genetics will find this book useful for understanding specific mutations and their implications for diseases.
-
Patients & Families
Individuals affected by polycythemia vera may find the information beneficial for understanding their condition and potential treatments.
-
General Audience
Individuals without a medical or scientific background may find the content too technical and difficult to understand.
Product Description
JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in polycythemia vera in the TABRIZ Paperback June 23, 2016
Customer Questions & Answers
-
Question:
What is the JAK2-V617F mutation and its significance in polycythemia vera?
Answer: The JAK2-V617F mutation is a genetic alteration commonly associated with polycythemia vera, a type of myeloproliferative disorder. This mutation leads to uncontrolled production of blood cells, which can increase the risk of blood clots and other cardiovascular complications. Understanding this mutation is crucial for diagnosis and treatment planning in patients with polycythemia vera, as it allows healthcare providers to tailor therapies based on the mutation's presence. -
Question:
Who is typically affected by polycythemia vera and the JAK2-V617F mutation?
Answer: Polycythemia vera primarily affects adults, with the highest incidence in individuals aged 60 and older. However, it can occur in younger individuals as well. The JAK2-V617F mutation is found in approximately 95% of polycythemia vera cases, making it a reliable biomarker for diagnosis. Individuals with a family history of blood disorders or a previous history of blood clots may have a higher risk. -
Question:
How is the JAK2-V617F mutation tested?
Answer: Testing for the JAK2-V617F mutation typically involves a blood sample analysis through polymerase chain reaction (PCR) techniques. This method allows for the detection of the specific genetic change in the JAK2 gene. The results help in confirming a diagnosis of polycythemia vera and can guide subsequent management and treatment decisions. -
Question:
What are the common symptoms of polycythemia vera related to the JAK2-V617F mutation?
Answer: Individuals with polycythemia vera often experience symptoms such as headaches, dizziness, and blurred vision due to increased blood viscosity. Other symptoms may include fatigue, itching after a hot shower, and a ruddy complexion. Recognizing these symptoms is crucial for early intervention, which can help manage complications arising from the mutation. -
Question:
Can the JAK2-V617F mutation be inherited?
Answer: The JAK2-V617F mutation is not directly inherited in a traditional sense, as it generally occurs sporadically during an individual’s lifetime. However, familial predispositions to myeloproliferative disorders may exist, indicating that genetic factors could play a role in risk. Understanding family medical history can aid in assessment and early detection of disorders associated with this mutation. -
Question:
What treatment options are available for patients with the JAK2-V617F mutation?
Answer: Treatment options for patients with the JAK2-V617F mutation primarily focus on controlling symptoms and reducing the risk of complications. Common approaches include phlebotomy to reduce red blood cell mass, low-dose aspirin to mitigate thrombotic risks, and newer targeted therapies like JAK inhibitors. These treatments may help significantly reduce symptoms and improve the quality of life for affected patients. -
Question:
How does the JAK2-V617F mutation impact the prognosis of polycythemia vera?
Answer: The presence of the JAK2-V617F mutation generally provides a clearer understanding of the disease and can influence prognosis. Patients with this mutation may respond better to certain targeted therapies, leading to improved management of the condition. Continuous monitoring and a personalized treatment approach can lead to a more favorable outcome, emphasizing the importance of early detection and regular follow-ups. -
Question:
What role does genetic counseling play for patients with the JAK2-V617F mutation?
Answer: Genetic counseling is vital for patients with the JAK2-V617F mutation, offering support in understanding the implications of the mutation on health, family planning, and potential risks. It helps patients make informed decisions regarding their care and empowers them to take proactive steps in managing their health condition in collaboration with their healthcare providers. -
Question:
Where can I buy 'JAK2-V617F Mutation In Polycythemia Vera Of Malta: Evaluation of patients with myeloproliferative disorders' in Malta?
Answer: You can purchase 'JAK2-V617F Mutation In Polycythemia Vera Of Malta: Evaluation of patients with myeloproliferative disorders' through Ubuy in Malta. Ubuy offers a convenient online shopping platform with access to various genetic research materials and books, ensuring that you can find the specific literature you're looking for with ease.
Genetics Editorial Review
Customer Reviews & Ratings
-
5 Star
100%
-
4 Star
0%
-
3 Star
0%
-
2 Star
0%
-
1 Star
0%
Review this product
Share your thoughts with other customers
Platform Trust & Buyer Confidence
“Excellent quality and original too,when ubuy send original things I will appreciate that ,I very satisfied thank you”
“The order and delivery progress was communicated very well. Package arrived within the estimated time. Products arrived as expected in good condition.”
“Good supply of products. Safe payment methods, and shipment worldwide! Genuine products.”
“Was my first time buying a product from Ubuy, but I found it so helpful. This is reliable. Gonna place a new order!”
“Ubuy is a great online platform to buy stuff. Reliable, fast delivery time and great value for money. I've been using Ubuy online shopping platform for three years now and will continue to do so.”
Product Price History
Important information
- Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
- Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.
€ 105
Order now and get it around Sunday, August 02
This item is not restrict in my country.(Please click on above link if this item is not restrict in your country, So our team will review and allow.)
QTY:
PCI DSS compliant and ISO 27001:2022 certified, with encrypted payments and full buyer protection on every order.
Features & Benefits
- Explore JAK2-V617F mutation's impact on polycythemia vera.
- Focus on hematological infectious diseases, including polycythemia.
- Identify the need for more research to address this growing issue.
- Highlight the increasing number of deaths due to polycythemia each year.
- Discuss the significance of chronic myeloproliferative disorders (MPDs).
- Emphasize potential breakthroughs from genetic studies for future cures.
Ubuy Assurance
Experience worry-free shopping with 100% original products, PCI DSS-compliant payment security, ISO 27001-certified data protection, the fastest cross-border delivery, free returns *, and secure packaging on every order.